# An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)

> **NCT07404644** · — · RECRUITING · sponsor: **Takeda** · enrollment: 13 (estimated)

## Conditions studied

- Von Willebrand Disease (vWD)

## Interventions

- **DRUG:** vonicog alfa (rVWF)

## Key facts

- **NCT ID:** NCT07404644
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-19
- **Primary completion:** 2031-05-30
- **Final completion:** 2031-05-30
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07404644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07404644, "An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07404644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*